SQK | Quantum-enhanced computing for next-generation medical imaging and diagnostics.

SQK is revolutionizing the medical imaging and diagnostics landscape with its innovative approach to quantum-enhanced computing. Focused on transforming the $50B+ imaging market, SQK integrates Quantum-Photonics-AI hybrid computing to deliver unprecedented capabilities in real-time, high-resolution medical imaging. This pioneering technology is set to redefine early disease detection and precision-guided treatment, offering safer, more cost-effective, and real-time solutions. SQK is headquartered in Seattle, US, with additional locations in Seoul, KR, and Sherbrooke, Quebec J1K 1B7, CA.

SQK's flagship platform, QMEDIC (Quantum-enhanced Medical Imaging & Diagnostics Computing), is engineered to overcome the computational limitations of existing imaging systems. By leveraging quantum acceleration, photonics integration, AI-driven reconstruction, and zero I/O memory pooling, QMEDIC enables non-invasive, radiation-free imaging modalities like photoacoustic and ultrasound to achieve diagnostic clarity previously only attainable with CT or MRI. This breakthrough enhances safety, reduces costs, and ensures real-time operation, making advanced medical imaging more accessible and efficient.

With a primary focus on oncology and pediatric applications, SQK is dedicated to providing safe and accurate imaging solutions critical for early detection and treatment guidance. The company's scalable architecture also extends to defense, life sciences, and industrial sensing, where ultrafast hybrid computing is essential. SQK is committed to validating QMEDIC in clinical and preclinical environments through collaborations with hospitals, OEMs, and research institutions. SQK continues to drive innovation and expand its impact across various sectors. We invite the company’s management to create a customized and exclusive company showcase and product listing on our platform.